Groton, CT, United States of America

Suobao Rong


 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Groton, CT (US) (2012 - 2013)
  • Doylestown, PA (US) (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Suobao Rong: Pioneering Treatments for Cognitive Deficits

Introduction: Suobao Rong, based in Groton, Connecticut, is an accomplished inventor with a significant contribution to the field of pharmaceuticals. With three patents to his name, Rong is recognized for his work in developing innovative treatments aimed at addressing cognitive deficits associated with schizophrenia and other neurological disorders. His research is crucial in enhancing the lives of those affected by these conditions.

Latest Patents: Suobao Rong's latest patents focus on KAT II inhibitors, specifically compounds of Formula I. These compounds, which include specific groups identified as X, Y, Z, R, R, R, and R, along with their pharmaceutically acceptable salts, are designed for the treatment of cognitive deficits in mammals, including humans. The potential applications of these inventions are vast, targeting not only schizophrenia but also various psychiatric and neurodegenerative disorders.

Career Highlights: Suobao Rong is currently associated with Pfizer Corporation, a leading player in the pharmaceutical industry. His work at Pfizer highlights his commitment to advancing medical science and developing innovative solutions to complex health challenges. With a focus on research and innovation, Suobao continues to make significant strides in his field.

Collaborations: Throughout his career, Suobao Rong has collaborated with talented colleagues, including Amy Beth Dounay and Patrick Robert Verhoest. These partnerships have fostered a dynamic environment for exchanging ideas and driving forward research initiatives aimed at improving treatment options for cognitive and neurological conditions.

Conclusion: Suobao Rong's work exemplifies the importance of innovation in the pharmaceutical industry. His recent patents on KAT II inhibitors underscore the potential for groundbreaking treatments that could significantly enhance quality of life for many individuals. As he continues to push the boundaries of research, Suobao Rong remains a key figure in the ongoing fight against cognitive deficits and related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…